In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death.

PubWeight™: 2.30‹?› | Rank: Top 2%

🔗 View Article (PMC 1223882)

Published in Biochem J on January 15, 2004

Authors

Heftsi Azoulay-Zohar1, Adrian Israelson, Salah Abu-Hamad, Varda Shoshan-Barmatz

Author Affiliations

1: Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

Articles citing this

(truncated to the top 100)

Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene (2006) 2.96

Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes. Nucleic Acids Res (2008) 2.70

Retracted Sirtuin-3 deacetylation of cyclophilin D induces dissociation of hexokinase II from the mitochondria. J Cell Sci (2010) 2.56

Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr (2007) 2.47

Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels. PLoS One (2008) 1.87

Regulation of hexokinase binding to VDAC. J Bioenerg Biomembr (2008) 1.73

Lipid-induced mitochondrial stress and insulin action in muscle. Cell Metab (2012) 1.71

Mitochondrial ion channels. Annu Rev Physiol (2007) 1.70

On the role of VDAC in apoptosis: fact and fiction. J Bioenerg Biomembr (2005) 1.68

Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Mol Cell Biol (2007) 1.65

Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron (2010) 1.65

Retracted Sirtuin-3 modulates Bak- and Bax-dependent apoptosis. J Cell Sci (2012) 1.64

VDAC regulation: role of cytosolic proteins and mitochondrial lipids. J Bioenerg Biomembr (2008) 1.60

Hexokinase regulates Bax-mediated mitochondrial membrane injury following ischemic stress. Kidney Int (2011) 1.58

Crystal packing analysis of murine VDAC1 crystals in a lipidic environment reveals novel insights on oligomerization and orientation. Channels (Austin) (2009) 1.57

The expression level of the voltage-dependent anion channel controls life and death of the cell. Proc Natl Acad Sci U S A (2006) 1.54

The therapeutic potential of mitochondrial channels in cancer, ischemia-reperfusion injury, and neurodegeneration. Mitochondrion (2011) 1.48

Oligomeric states of the voltage-dependent anion channel and cytochrome c release from mitochondria. Biochem J (2005) 1.43

Potential therapeutic benefits of strategies directed to mitochondria. Antioxid Redox Signal (2010) 1.40

Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis. Liver Int (2014) 1.40

Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study. Biochem J (2004) 1.37

VDAC closure increases calcium ion flux. Biochim Biophys Acta (2007) 1.36

Uncovering the role of VDAC in the regulation of cell life and death. J Bioenerg Biomembr (2008) 1.34

Subcellular localization of hexokinases I and II directs the metabolic fate of glucose. PLoS One (2011) 1.32

Oligomerization of the mitochondrial protein voltage-dependent anion channel is coupled to the induction of apoptosis. Mol Cell Biol (2010) 1.30

Mitochondria-associated hexokinases play a role in the control of programmed cell death in Nicotiana benthamiana. Plant Cell (2006) 1.28

The metabolic advantage of tumor cells. Mol Cancer (2011) 1.24

Free tubulin modulates mitochondrial membrane potential in cancer cells. Cancer Res (2010) 1.23

Protein kinases and phosphatases in the control of cell fate. Enzyme Res (2011) 1.23

VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J Bioenerg Biomembr (2008) 1.21

A dominant mutation in hexokinase 1 (HK1) causes retinitis pigmentosa. Invest Ophthalmol Vis Sci (2014) 1.20

Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue. J Bioenerg Biomembr (2009) 1.20

Reduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reperfusion injury. Circ Res (2010) 1.20

Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death. Proc Natl Acad Sci U S A (2012) 1.19

VDAC1: from structure to cancer therapy. Front Oncol (2012) 1.16

Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury. Front Physiol (2011) 1.14

Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity. J Biol Chem (2009) 1.13

Affixing N-terminal α-helix to the wall of the voltage-dependent anion channel does not prevent its voltage gating. J Biol Chem (2012) 1.13

Nuclear and mitochondrial signalling Akts in cardiomyocytes. Cardiovasc Res (2009) 1.09

The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death. J Biol Chem (2007) 1.07

Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production. EMBO Mol Med (2012) 1.07

Nek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1. Cell Cycle (2009) 1.03

HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. PLoS One (2013) 1.01

The role of VDAC in cell death: friend or foe? Biochim Biophys Acta (2011) 0.99

Amyloid-β triggers the release of neuronal hexokinase 1 from mitochondria. PLoS One (2010) 0.98

Warburg revisited: regulation of mitochondrial metabolism by voltage-dependent anion channels in cancer cells. J Pharmacol Exp Ther (2012) 0.94

The voltage-dependent anion channel in endoplasmic/sarcoplasmic reticulum: characterization, modulation and possible function. J Membr Biol (2005) 0.94

Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo. Mol Ther Nucleic Acids (2014) 0.92

Regulation and cytoprotective role of hexokinase III. PLoS One (2010) 0.92

ATP/ADP ratio, the missed connection between mitochondria and the Warburg effect. Mitochondrion (2014) 0.92

Increased hexokinase II expression in the renal glomerulus of mice in response to arsenic. Toxicol Appl Pharmacol (2007) 0.91

Chicken or the egg: Warburg effect and mitochondrial dysfunction. F1000Prime Rep (2015) 0.91

Hexokinase activity is required for recruitment of parkin to depolarized mitochondria. Hum Mol Genet (2013) 0.90

A message emerging from development: the repression of mitochondrial beta-F1-ATPase expression in cancer. J Bioenerg Biomembr (2007) 0.90

Long-chain ceramide is a potent inhibitor of the mitochondrial permeability transition pore. J Biol Chem (2008) 0.90

Mitochondrial membrane potential is regulated by vimentin intermediate filaments. FASEB J (2014) 0.88

Determination of ACC-induced cell-programmed death in roots of Vicia faba ssp. minor seedlings by acridine orange and ethidium bromide staining. Protoplasma (2012) 0.87

The mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell death. Front Oncol (2014) 0.87

Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's. PLoS One (2013) 0.86

Biphasic effect of nitric oxide on the cardiac voltage-dependent anion channel. FEBS Lett (2010) 0.86

Dichloroacetate prevents restenosis in preclinical animal models of vessel injury. Nature (2014) 0.85

Transfer of a Redox-Signal through the Cytosol by Redox-Dependent Microcompartmentation of Glycolytic Enzymes at Mitochondria and Actin Cytoskeleton. Front Plant Sci (2013) 0.85

Acidification asymmetrically affects voltage-dependent anion channel implicating the involvement of salt bridges. J Biol Chem (2014) 0.84

Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damage. Biochim Biophys Acta (2013) 0.84

VDAC: old protein with new roles in diabetes. Am J Physiol Cell Physiol (2012) 0.84

The role of hexokinase in cardioprotection - mechanism and potential for translation. Br J Pharmacol (2014) 0.84

VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia. Cell Death Dis (2013) 0.84

Role of hexokinase-1 in the survival of HIV-1-infected macrophages. Cell Cycle (2015) 0.83

Regulation of mitochondrial function by voltage dependent anion channels in ethanol metabolism and the Warburg effect. Biochim Biophys Acta (2011) 0.83

Antibodies against the voltage-dependent anion channel (VDAC) and its protective ligand hexokinase-I in children with autism. J Neuroimmunol (2010) 0.83

Myostatin induces mitochondrial metabolic alteration and typical apoptosis in cancer cells. Cell Death Dis (2013) 0.82

Revisiting trends on mitochondrial mega-channels for the import of proteins and nucleic acids. J Bioenerg Biomembr (2016) 0.82

Bcl-2 proteins and calcium signaling: complexity beneath the surface. Oncogene (2016) 0.81

Voltage-dependent anion channel 2 of Arabidopsis thaliana (AtVDAC2) is involved in ABA-mediated early seedling development. Int J Mol Sci (2009) 0.81

Hexokinases and cardioprotection. J Mol Cell Cardiol (2014) 0.81

Oncogenic and oncosuppressive signal transduction at mitochondria-associated endoplasmic reticulum membranes. Mol Cell Oncol (2014) 0.81

The regulation of apoptosis by the downstream regulatory element antagonist modulator/potassium channel interacting protein 3 (DREAM/KChIP3) through interactions with hexokinase I. Biochem Biophys Res Commun (2013) 0.81

The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy. J Biol Chem (2015) 0.81

Hexokinase I N-terminal based peptide prevents the VDAC1-SOD1 G93A interaction and re-establishes ALS cell viability. Sci Rep (2016) 0.80

Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction. J Biol Chem (2016) 0.80

Glycolytic switch in response to betulinic acid in non-cancer cells. PLoS One (2014) 0.79

Mitochondrial VDAC and hexokinase together modulate plant programmed cell death. Protoplasma (2012) 0.79

HK2 is a radiation resistant and independent negative prognostic factor for patients with locally advanced cervical squamous cell carcinoma. Int J Clin Exp Pathol (2015) 0.79

Characterization of human septic sera induced gene expression modulation in human myocytes. Int J Clin Exp Med (2009) 0.78

Computational investigation of cholesterol binding sites on mitochondrial VDAC. J Phys Chem B (2014) 0.78

Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment. PLoS One (2016) 0.77

Does the voltage dependent anion channel modulate cardiac ischemia-reperfusion injury? Biochim Biophys Acta (2011) 0.77

Is amyotrophic lateral sclerosis a mitochondrial channelopathy? Neuron (2010) 0.76

Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT. Eur Radiol (2015) 0.76

Metabolic remodeling precedes mitochondrial outer membrane permeabilization in human glioma xenograft cells. Int J Oncol (2011) 0.76

Investigating Effects of Acidic pH on Proliferation, Invasion and Drug-Induced Apoptosis in Lymphoblastic Leukemia. Cancer Microenviron (2016) 0.76

Yeast mitochondrial interactosome model: metabolon membrane proteins complex involved in the channeling of ADP/ATP. Int J Mol Sci (2012) 0.75

News about VDAC1 in Hypoxia. Front Oncol (2016) 0.75

The Relationship Between Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Expression of Breast Cancer and the Retention Index in Dual Phase (18)F-FDG PET/CT. Nucl Med Mol Imaging (2016) 0.75

Antitumoural activity of a cytotoxic peptide of Lactobacillus casei peptidoglycan and its interaction with mitochondrial-bound hexokinase. Anticancer Drugs (2016) 0.75

VDAC3 As a Potential Marker of Mitochondrial Status Is Involved in Cancer and Pathology. Front Oncol (2016) 0.75

VDAC-Tubulin, an Anti-Warburg Pro-Oxidant Switch. Front Oncol (2017) 0.75

Regulation of VDAC trafficking modulates cell death. Cell Death Discov (2016) 0.75

The Mitochondrial Voltage-Dependent Anion Channel 1, Ca(2+) Transport, Apoptosis, and Their Regulation. Front Oncol (2017) 0.75

Thyroid states regulate subcellular glucose phosphorylation activity in male mice. Endocr Connect (2017) 0.75

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell (1993) 20.72

Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell (1996) 16.73

The Bcl-2 protein family: arbiters of cell survival. Science (1998) 16.08

The mitochondrial permeability transition pore and its role in cell death. Biochem J (1999) 7.72

The mitochondrial permeability transition. Biochim Biophys Acta (1995) 7.14

Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev (2001) 5.12

The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol (2001) 3.66

Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem (2001) 3.33

Permeation of hydrophilic solutes through mitochondrial outer membranes: review on mitochondrial porins. Biochim Biophys Acta (1994) 2.20

VDAC channels mediate and gate the flow of ATP: implications for the regulation of mitochondrial function. Biophys J (1997) 2.09

From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim Biophys Acta (1998) 2.07

Hexokinases. Rev Physiol Biochem Pharmacol (1995) 2.03

Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP. J Biol Chem (1988) 1.97

Regulation of metabolite flux through voltage-gating of VDAC channels. J Membr Biol (1997) 1.94

Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta (2002) 1.79

The voltage-dependent anion channel: an essential player in apoptosis. Biochimie (2002) 1.75

Calcium binding and translocation by the voltage-dependent anion channel: a possible regulatory mechanism in mitochondrial function. Biochem J (2001) 1.70

Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim Biophys Acta (1998) 1.64

Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem (1981) 1.63

Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells. J Cell Biol (2001) 1.57

Mitochondria and cell death. Biochem Soc Trans (2000) 1.51

Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death. J Bioenerg Biomembr (1999) 1.46

Pore protein and the hexokinase-binding protein from the outer membrane of rat liver mitochondria are identical. FEBS Lett (1982) 1.43

The mitochondrial permeability transition pore. Biochem Soc Symp (1999) 1.43

The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis. Acta Biochim Pol (2003) 1.37

Permeabilization of the mitochondrial inner membrane during apoptosis: impact of the adenine nucleotide translocator. Cell Death Differ (2000) 1.36

Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death. J Biol Chem (2001) 1.31

Specificity for the glucose-6-P inhibition site of hexokinase. Arch Biochem Biophys (1974) 1.30

The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition. Biofactors (1998) 1.18

Rat brain hexokinase: the hydrophobic N-terminus of the mitochondrially bound enzyme is inserted in the lipid bilayer. Arch Biochem Biophys (1988) 1.13

Allosteric inhibition of the Ca2+-activated hydrophilic channel of the mitochondrial inner membrane by nucleotides. J Membr Biol (1980) 1.07

Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages. Biochim Biophys Acta (1994) 1.07

Modulation of the voltage-dependent anion channel (VDAC) by glutamate. J Bioenerg Biomembr (2000) 1.03

Characterization of porin isoforms expressed in tumor cells. Eur J Biochem (2000) 1.00

Studies on human porin. VI. Production and characterization of eight monoclonal mouse antibodies against the human VDAC "Porin 31HL" and their application for histotopological studies in human skeletal muscle. Biol Chem Hoppe Seyler (1991) 0.99

Tetrameric structure of mitochondrially bound rat brain hexokinase: a crosslinking study. Arch Biochem Biophys (1990) 0.96

Rapid purification of mitochondrial hexokinase from rat brain by a single affinity chromatography step on Affi-Gel blue. Prep Biochem (1989) 0.93

Membrane potential-dependent conformational changes in mitochondrially bound hexokinase of brain. Arch Biochem Biophys (2000) 0.93

Binding of rat brain hexokinase to recombinant yeast mitochondria: effect of environmental factors and the source of porin. J Bioenerg Biomembr (1998) 0.89

Glycolysis and growth rate in normal and in hexokinase-transfected NIH-3T3 cells. Oncol Res (1994) 0.86

Insulin-like growth factor I induces tumor hexokinase RNA expression in cancer cells. Biochem Biophys Res Commun (1997) 0.84

Binding of rat brain hexokinase to recombinant yeast mitochondria: identification of necessary physico-chemical determinants. Eur J Biochem (2000) 0.84

The nonspecific inner membrane pore of liver mitochondria: modulation of cyclosporin sensitivity by ADP at carboxyatractyloside-sensitive and insensitive sites. Biochem Biophys Res Commun (1991) 0.81

Articles by these authors

NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc Natl Acad Sci U S A (2009) 2.36

Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron (2010) 1.65

The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins. J Cell Sci (2009) 1.65

Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding. J Biol Chem (2008) 1.65

The expression level of the voltage-dependent anion channel controls life and death of the cell. Proc Natl Acad Sci U S A (2006) 1.54

Oligomeric states of the voltage-dependent anion channel and cytochrome c release from mitochondria. Biochem J (2005) 1.43

Oligomerization of the mitochondrial protein voltage-dependent anion channel is coupled to the induction of apoptosis. Mol Cell Biol (2010) 1.30

ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc Natl Acad Sci U S A (2010) 1.26

Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo. Biochim Biophys Acta (2010) 1.16

Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its anti-apoptotic activity. J Biol Chem (2008) 1.13

Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity. J Biol Chem (2009) 1.13

Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein. J Biol Chem (2012) 1.11

Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase. Biochim Biophys Acta (2008) 1.09

Nucleotide-binding sites in the voltage-dependent anion channel: characterization and localization. J Biol Chem (2005) 0.97

Expression of a truncated active form of VDAC1 in lung cancer associates with hypoxic cell survival and correlates with progression to chemotherapy resistance. Cancer Res (2012) 0.95

ATP-binding sites in brain p97/VCP (valosin-containing protein), a multifunctional AAA ATPase. Biochem J (2003) 0.93

Structure-based analysis of VDAC1: N-terminus location, translocation, channel gating and association with anti-apoptotic proteins. Biochem J (2012) 0.93

Downregulation of voltage-dependent anion channel-1 expression by RNA interference prevents cancer cell growth in vivo. Cancer Biol Ther (2010) 0.93

Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death. FEBS Lett (2005) 0.92

Structure-based analysis of VDAC1 protein: defining oligomer contact sites. J Biol Chem (2011) 0.90

The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis. Biochim Biophys Acta (2013) 0.90

VDAC1 cysteine residues: topology and function in channel activity and apoptosis. Biochem J (2010) 0.88

Localization of the voltage-dependent anion channel-1 Ca2+-binding sites. Cell Calcium (2006) 0.88

Characterization of DIDS-sensitive ATP accumulation in brain synaptic vesicles. FEBS Lett (2006) 0.87

Dominant-negative VDAC1 mutants reveal oligomeric VDAC1 to be the active unit in mitochondria-mediated apoptosis. Biochem J (2010) 0.85

Retinal voltage-dependent anion channel: characterization and cellular localization. Invest Ophthalmol Vis Sci (2002) 0.84

A photoactivable probe for calcium binding proteins. Chem Biol (2005) 0.83

An N-terminal nucleotide-binding site in VDAC1: involvement in regulating mitochondrial function. J Cell Physiol (2007) 0.83

The synaptic vesicle protein synaptophysin: purification and characterization of its channel activity. Biophys J (2002) 0.82

Glutamate interacts with VDAC and modulates opening of the mitochondrial permeability transition pore. J Bioenerg Biomembr (2004) 0.82

Mapping the ruthenium red-binding site of the voltage-dependent anion channel-1. Cell Calcium (2007) 0.80

Measurement of mitochondrial Ca2+ transport mediated by three transport proteins: VDAC1, the Na+/Ca2+ exchanger, and the Ca2+ uniporter. Cold Spring Harb Protoc (2014) 0.78

Purification of VDAC1 from rat liver mitochondria. Cold Spring Harb Protoc (2014) 0.77

Assays of mitochondrial Ca2+ transport and Ca2+ efflux via the MPTP. Cold Spring Harb Protoc (2014) 0.76

Reconstitution of purified VDAC1 into a lipid bilayer and recording of channel conductance. Cold Spring Harb Protoc (2014) 0.76

A chemical chaperone-based drug candidate is effective in a mouse model of amyotrophic lateral sclerosis (ALS). ChemMedChem (2015) 0.76

Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo. Mol Ther Nucleic Acids (2017) 0.75

Azido ruthenium: a new photoreactive probe for calcium-binding proteins. Nat Protoc (2006) 0.75

New fluorescent reagents specific for Ca(2+)-binding proteins. Biochem Biophys Res Commun (2012) 0.75

Mitochondrial Na+/Ca2+ exchange assays. Cold Spring Harb Protoc (2014) 0.75

Assay of Ca2+ transport by VDAC1 reconstituted into liposomes. Cold Spring Harb Protoc (2014) 0.75